Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer

Hajer Ziouziou(Inserm), Palma Rocchi(Centre National de la Recherche Scientifique)
Pharmaceutics
April 27, 2021
10.3390/pharmaceutics13050623
Cited by 11

Related Papers

OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer
|Cell Death and Disease|2011|100
Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
|Oncotarget|2017|11
Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment
|Biomedicines|2021|11